While it cost around $200 billion to treat cancer in the US in 2020, the total expense is anticipated ... Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells healthcare ...

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1. ...

2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, demonstrating strong performance across its business segments.

The Leon’s getting on a bit now though, so does a power boost from Abt elevate the Leon back to its position near the top of the class, or would your money be better spent elsewhere? We’ve ...